Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into the therapy response. By combining proven approaches to measuring DNA with cutting-edge technology to improve accuracy and sensitivity Cadex Genomics provides unique insight into therapy response using simple blood draws.

Biotechnology

Cadex Genomics

Bill Haack

Kevin Knopf MD MPH

Alf Merriweather

Patrick Hall

Sudhir Sinha

The executive team at Cadex Genomics has experience in the field of genomic science and medical affairs. They have worked with various companies in the past, such as Castle Biosciences, Inc. and Genomic Health. They also have a strong educational background, with degrees from the University of Oklahoma Health Sciences Center and the College of Pharmacy.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Cadex Genomics

Board of Directors

Leadership Team